Inventor · disambiguated record
Robert M. Chanock
Also filed as: CHANOCK ROBERT · CHANOCK ROBERT M
35 granted patents·1 pending application·1,027 citations·filing 1975–2020
98Inventor score
Files withUS HEALTH21DYNCORP4SCRIPPS RESEARCH INST3PILKINGTON GLENN R2ST JUDE CHILDRENS RES HOSPITAL2
Top patents by PatentIndex Score
36 records- 0194US5922326AAttenuated respiratory syncytial virus vaccine compositionsUS HEALTH·Filed 1994·Granted Jul 13, 1999·109 cites·26 claims
- 0294US5762905AHuman neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 1993·Granted Jun 9, 1998·112 cites·29 claims
- 0393US3992522ATemperature-sensitive recombinant mutant viruses and a process for producing sameUS HEALTH EDUCATION & WELFARE·Filed 1975·Granted Nov 16, 1976·86 cites·5 claims
- 0492US6184024B1Chimeric and/or growth-restricted flavivirusesUS HEALTH·Filed 1994·Granted Feb 6, 2001·140 cites·52 claims
- 0591US8221759B2Neutralizing monoclonal antibodies to respiratory syncytial virusPILKINGTON GLENN R·Filed 2011·Granted Jul 17, 2012·19 cites·1 claims
- 0691US7488477B2Neutralizing monoclonal antibodies to respiratory syncytial virusINTRACEL RESOURCES LLC·Filed 2003·Granted Feb 10, 2009·37 cites·1 claims
- 0790US7364737B2Human neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 2004·Granted Apr 29, 2008·18 cites·16 claims
- 0890US6685942B1Human neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 1997·Granted Feb 3, 2004·64 cites·16 claims
- 0990US4800078AImmunotherapeutic method of treating respiratory disease by intranasal administration of IgbUS HEALTH·Filed 1987·Granted Jan 24, 1989·105 cites·1 claims
- 1089US6676936B1Chimeric and/or growth-restricted flavivirusesUS HEALTH·Filed 2000·Granted Jan 13, 2004·25 cites·5 claims
- 1188US6497884B1Chimeric vaccine against tick-borne encephalitis virusUS HEALTH·Filed 2000·Granted Dec 24, 2002·24 cites·9 claims
- 1287US6660273B2Chimeric vaccine against tick-borne encephalitis virusUS HEALTH·Filed 2002·Granted Dec 9, 2003·20 cites·10 claims
- 1387US4552758AHuman use of avian-human reassortants as vaccines for influenza A virusST JUDE CHILDRENS RES HOSPITAL·Filed 1983·Granted Nov 12, 1985·73 cites·2 claims
- 1482US10058602B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2014·Granted Aug 28, 2018·3 cites·15 claims
- 1576US11400150B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2020·Granted Aug 2, 2022·0 cites·9 claims
- 1675US4571385AGenetic reassortment of rotaviruses for production of vaccines and vaccine precursorsUS HEALTH·Filed 1983·Granted Feb 18, 1986·39 cites·7 claims
- 1771US8778671B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusPLETNEV ALEXANDER G·Filed 2004·Granted Jul 15, 2014·4 cites·6 claims
- 1869US10869920B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2019·Granted Dec 22, 2020·0 cites·11 claims
- 1967US2009110684A1Neutralizing monoclonal antibodies to respiratory syncytial virusPILKINGTON GLENN R·Filed 2008·Application pending·0 cites
- 2066US10456461B2Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virusUS HEALTH·Filed 2018·Granted Oct 29, 2019·0 cites·12 claims
- 2163US5911998AMethod of producing a virus vaccine from an African green monkey kidney cell lineDYNCORP·Filed 1997·Granted Jun 15, 1999·14 cites·4 claims
- 2262US5882651AAttenuated respiratory syncytial virus vaccine compositionsUS HEALTH·Filed 1995·Granted Mar 16, 1999·19 cites·16 claims
- 2362US4927628AVaccine against rotavirus diseases and method of preparing sameUS HEALTH·Filed 1987·Granted May 22, 1990·24 cites·2 claims
- 2461US4341870ACultivatable human rotavirus type 2US HEALTH·Filed 1980·Granted Jul 27, 1982·20 cites·2 claims
- 2558US4704275AVaccine against rotavirus diseasesUS HEALTH·Filed 1985·Granted Nov 3, 1987·24 cites·2 claims
- 2657US7150984B2Attenuated human rotavirus vaccineUS HEALTH·Filed 1995·Granted Dec 19, 2006·13 cites·49 claims
- 2755US4751080AVaccine against rotavirus diseasesUS HEALTH·Filed 1987·Granted Jun 14, 1988·21 cites·2 claims
- 2849US8168202B2Hexavalent bovine rotavirus reassortant composition designed for use in developing countriesKAPIKIAN ALBERT Z·Filed 2006·Granted May 1, 2012·0 cites·9 claims
- 2949US6794174B2Full-length infectious cDNA clones of tick borne flavivirusUS HEALTH·Filed 2002·Granted Sep 21, 2004·0 cites·20 claims
- 3042US7431931B2Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositionsUS HEALTH·Filed 2001·Granted Oct 7, 2008·0 cites·14 claims
- 3142US6284254B1Immunogenic compositions comprising cold-adapted attenuated respiratory syncytial virus mutantsUS HEALTH·Filed 1995·Granted Sep 4, 2001·5 cites·12 claims
- 3240US4552757AUse in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virusST JUDE CHILDRENS RES HOSPITAL·Filed 1983·Granted Nov 12, 1985·5 cites·6 claims
- 3339US6025182AMethod for producing a virus from an african green monkey kidney cell lineDYNCORP·Filed 1998·Granted Feb 15, 2000·2 cites·8 claims
- 3435US6117667AMethod for producing an adapted virus population from an African green monkey kidney cell lineDYNCORP·Filed 1999·Granted Sep 12, 2000·1 cites·12 claims
- 3532US5646033AAfrican green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccinesDYNCORP·Filed 1994·Granted Jul 8, 1997·1 cites·1 claims
- 3630US7932074B1Multivalent human-bovine rotavirus vaccineUS HEALTH·Filed 1999·Granted Apr 26, 2011·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Robert M. Chanock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →